| HGNC Family | Tumor necrosis factor receptor superfamily (TNFRSF), CD molecules (CD) |
| Name | tumor necrosis factor receptor superfamily, member 9 |
| Description | The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTNFRSF9, also known as CD137 or 4‑1BB, is a member of the tumor necrosis factor receptor superfamily that is transiently expressed on activated lymphocytes—including T cells, natural killer cells, and even nonimmune cells such as endothelial and neural cells—and plays a critical role in costimulatory signaling. Engagement of TNFRSF9 by its ligand or agonistic antibodies promotes lymphocyte activation, proliferation, and survival by inducing key signaling pathways (e.g., via NF‑κB and anti‐apoptotic mediators) and by enhancing cytokine secretion, thereby shaping effector and memory cell responses. This receptor is also rapidly upregulated on antigen‐stimulated or virus‐specific T cells, making it a sensitive marker for isolating activated as well as alloreactive T cells in diverse immunologic and clinical settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of adoptive immunotherapy and chimeric antigen receptor (CAR) T‑cell strategies, TNFRSF9 costimulation has emerged as a pivotal regulatory element. Incorporation of TNFRSF9 signaling domains into CAR constructs enhances T‑cell expansion, persistence, and antitumor efficacy by sustaining noncanonical NF‑κB activation and by promoting the generation of central memory and effector subsets with a preferential Th1 cytokine profile. Moreover, agonistic targeting of TNFRSF9 can rescue T‑cell populations from exhaustion, augment natural killer cell function, and even improve the expansion and functional stability of regulatory T cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "10"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in promoting lymphocyte activation and survival, TNFRSF9 is instrumental in modulating the tumor microenvironment and in maintaining immune homeostasis. Its expression on infiltrating T cells within lymphomas and solid tumors not only serves as an important prognostic biomarker but also can influence therapeutic responses, as seen in the improvement of antibody‐mediated cytotoxicity and in the recruitment and modulation of dendritic cells. Mutations in TNFRSF9 are associated with impaired T‑cell expansion and the development of virus‐associated lymphoproliferative disorders, underscoring its essential function in host immunity. Structural studies have revealed that TNFRSF9 forms disulfide‐linked dimers that, through multivalent binding to its ligand, can amplify downstream costimulatory signals—a property being exploited in novel oncolytic and combination immunotherapies—while soluble forms of the receptor are emerging as potential biomarkers in inflammatory and cardiovascular diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Diego Laderach, Mojgan Movassagh, Anthony Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/intimm/dxf080"}], "href": "https://doi.org/10.1093/intimm/dxf080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12356681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12356681"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Young-June Kim, Randy R Brutkiewicz, Hal E Broxmeyer "}, {"type": "b", "children": [{"type": "t", "text": "Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2001-11-0136"}], "href": "https://doi.org/10.1182/blood-2001-11-0136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12384425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12384425"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Vadim Y Taraban, Tania F Rowley, Lyn O'Brien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1521-4141(200212)32:12"}, {"type": "a", "children": [{"type": "t", "text": "3617::AID-IMMU3617"}], "href": "3617::AID-IMMU3617"}, {"type": "t", "text": "3.0.CO;2-M"}], "href": "https://doi.org/10.1002/1521-4141(200212"}, {"type": "t", "text": "32:12"}, {"type": "a", "children": [{"type": "t", "text": "3617::AID-IMMU3617"}], "href": "3617::AID-IMMU3617"}, {"type": "t", "text": "3.0.CO;2-M) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12516549"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12516549"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Camilla Reali, Monica Curto, Valeria Sogos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jnr.10727"}], "href": "https://doi.org/10.1002/jnr.10727"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "13130507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/13130507"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hyo Won Jung, Seung Won Choi, Jung I L Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Med (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emm.2004.2"}], "href": "https://doi.org/10.1038/emm.2004.2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15031666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15031666"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Herbert Schwarz "}, {"type": "b", "children": [{"type": "t", "text": "Biological activities of reverse signal transduction through CD137 ligand."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.0904558"}], "href": "https://doi.org/10.1189/jlb.0904558"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15618293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15618293"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Bruce Y Ma, Sebastian A Mikolajczak, Ali Danesh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-04-1622"}], "href": "https://doi.org/10.1182/blood-2004-04-1622"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15941918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15941918"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hua Zhang, Kristen M Snyder, Megan M Suhoski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.179.7.4910"}], "href": "https://doi.org/10.4049/jimmunol.179.7.4910"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17878391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17878391"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Edward C P Waller, Nicola McKinney, Ray Hicks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific \"effector memory\" (CD28(-) CD45RA(HI)) CD8(+) T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-07-104604"}], "href": "https://doi.org/10.1182/blood-2007-07-104604"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17878400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17878400"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Klemens Pichler, Tarek Kattan, Juliane Gentzsch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-10-115220"}], "href": "https://doi.org/10.1182/blood-2007-10-115220"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18276843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18276843"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Keli L Hippen, Paul Harker-Murray, Stephen B Porter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-01-132951"}], "href": "https://doi.org/10.1182/blood-2008-01-132951"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18645038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18645038"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Inmaculada Rioja, Fiona J Hughes, Catriona H Sharp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheum (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.23667"}], "href": "https://doi.org/10.1002/art.23667"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18668547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18668547"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Carmine Carpenito, Michael C Milone, Raffit Hassan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0813101106"}], "href": "https://doi.org/10.1073/pnas.0813101106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19211796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19211796"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Liu Dongming, Lu Zuxun, Xu Liangjie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2009.12.011"}], "href": "https://doi.org/10.1016/j.cca.2009.12.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20026323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20026323"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "En Hui Hsieh, Xiomara Fernandez, Jing Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 is required for M cell functional maturation but not lineage commitment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2010.090811"}], "href": "https://doi.org/10.2353/ajpath.2010.090811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20616340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20616340"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhe Shao, Herbert Schwarz "}, {"type": "b", "children": [{"type": "t", "text": "CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.0510315"}], "href": "https://doi.org/10.1189/jlb.0510315"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20643812"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20643812"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ash A Alizadeh, Andrew J Gentles, Alvaro J Alencar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2011-03-345272"}], "href": "https://doi.org/10.1182/blood-2011-03-345272"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21670469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21670469"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Paramita Baruah, Michael Lee, Tunde Odutoye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunobiology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.imbio.2011.11.005"}], "href": "https://doi.org/10.1016/j.imbio.2011.11.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22204816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22204816"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Ingrid E Dumitriu, Paramita Baruah, Caroline J Finlayson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.111.261933"}], "href": "https://doi.org/10.1161/CIRCRESAHA.111.261933"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22282196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22282196"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Álvaro Teijeira, Asís Palazón, Saray Garasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.11-201061"}], "href": "https://doi.org/10.1096/fj.11-201061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22593548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22593548"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Seung-Woo Lee, Yunji Park, So-Young Eun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1201248"}], "href": "https://doi.org/10.4049/jimmunol.1201248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22896640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22896640"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Matthew W Anderson, Shuchun Zhao, Aharon G Freud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2012.05.015"}], "href": "https://doi.org/10.1016/j.ajpath.2012.05.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22901750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22901750"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Qunrui Ye, De-Gang Song, Mathilde Poussin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-13-0945"}], "href": "https://doi.org/10.1158/1078-0432.CCR-13-0945"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24045181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24045181"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shravan Madireddi, So-Young Eun, Seung-Woo Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20132687"}], "href": "https://doi.org/10.1084/jem.20132687"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24958847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24958847"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Claudia Stuehler, Justyna Nowakowska, Claudia Bernardini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Infect Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/infdis/jiu607"}], "href": "https://doi.org/10.1093/infdis/jiu607"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25367298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25367298"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Mayumi Yoshimori, Ken-Ichi Imadome, Honami Komatsu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0112564"}], "href": "https://doi.org/10.1371/journal.pone.0112564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25409517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25409517"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Adrienne H Long, Waleed M Haso, Jack F Shern, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3838"}], "href": "https://doi.org/10.1038/nm.3838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25939063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25939063"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Miguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-3510"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-3510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26113085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26113085"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2016.01.021"}], "href": "https://doi.org/10.1016/j.immuni.2016.01.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26885860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26885860"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Raghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-16-0879"}], "href": "https://doi.org/10.1158/1078-0432.CCR-16-0879"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27496866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27496866"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Wenpeng Li, Linjie Guo, Purva Rathi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Gene Ther (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/hum.2016.025"}], "href": "https://doi.org/10.1089/hum.2016.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27530312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27530312"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jason B Williams, Brendan L Horton, Yan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20160485"}], "href": "https://doi.org/10.1084/jem.20160485"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28115575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28115575"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-0285"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-0285"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28536305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28536305"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Diogo Gomes-Silva, Malini Mukherjee, Madhuwanti Srinivasan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2017.09.015"}], "href": "https://doi.org/10.1016/j.celrep.2017.09.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28978471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28978471"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Aruna Bitra, Tzanko Doukov, Michael Croft, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.003176"}], "href": "https://doi.org/10.1074/jbc.RA118.003176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29720398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29720398"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Neil S Lagali, Reza A Badian, Xu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dendritic cell maturation in the corneal epithelium with onset of type 2 diabetes is associated with tumor necrosis factor receptor superfamily member 9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-32410-5"}], "href": "https://doi.org/10.1038/s41598-018-32410-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30250206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30250206"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Carter M Suryadevara, Rupen Desai, S Harrison Farber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-18-1211"}], "href": "https://doi.org/10.1158/1078-0432.CCR-18-1211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30425092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30425092"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Hyung-Don Kim, Seongyeol Park, Seongju Jeong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " T Cells in Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.30881"}], "href": "https://doi.org/10.1002/hep.30881"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31353502"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31353502"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Ido Somekh, Marini Thian, David Medgyesi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.2019000644"}], "href": "https://doi.org/10.1182/blood.2019000644"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31501153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31501153"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Rémy Rodriguez, Benjamin Fournier, Debora Jorge Cordeiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Concomitant "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "PIK3CD"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "TNFRSF9"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " deficiencies cause chronic active Epstein-Barr virus infection of T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20190678"}], "href": "https://doi.org/10.1084/jem.20190678"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31537641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31537641"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Benjamin I Philipson, Roddy S O'Connor, Michael J May, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.aay8248"}], "href": "https://doi.org/10.1126/scisignal.aay8248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32234960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32234960"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "A Stoll, H Bruns, M Fuchs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41375-021-01287-1"}], "href": "https://doi.org/10.1038/s41375-021-01287-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34021248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34021248"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Baptiste Lamarthée, Armance Marchal, Soëli Charbonnier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-26844-1"}], "href": "https://doi.org/10.1038/s41467-021-26844-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34750385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34750385"}]}]}]}
|
| Synonyms | ILA, 4-1BB, CD137, CDW137 |
| Proteins | TNR9_HUMAN |
| NCBI Gene ID | 3604 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TNFRSF9 has 6,484 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 111 datasets.
Click the + buttons to view associations for TNFRSF9 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF9 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving TNFRSF9 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF9 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFRSF9 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFRSF9 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TNFRSF9 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF9 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF9 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with TNFRSF9 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TNFRSF9 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF9 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TNFRSF9 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TNFRSF9 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with TNFRSF9 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing TNFRSF9 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF9 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TNFRSF9 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TNFRSF9 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TNFRSF9 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF9 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TNFRSF9 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TNFRSF9 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TNFRSF9 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TNFRSF9 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TNFRSF9 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TNFRSF9 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TNFRSF9 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TNFRSF9 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TNFRSF9 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFRSF9 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF9 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TNFRSF9 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TNFRSF9 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TNFRSF9 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TNFRSF9 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF9 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TNFRSF9 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TNFRSF9 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TNFRSF9 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TNFRSF9 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TNFRSF9 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TNFRSF9 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TNFRSF9 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TNFRSF9 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF9 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TNFRSF9 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Protein Ligands of Receptors | ligands (protein) binding TNFRSF9 receptor from the curated Guide to Pharmacology Protein Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TNFRSF9 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TNFRSF9 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TNFRSF9 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF9 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF9 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF9 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TNFRSF9 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TNFRSF9 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with TNFRSF9 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with TNFRSF9 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with TNFRSF9 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TNFRSF9 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by TNFRSF9 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TNFRSF9 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TNFRSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TNFRSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TNFRSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TNFRSF9 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving TNFRSF9 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF9 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TNFRSF9 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFRSF9 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TNFRSF9 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TNFRSF9 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF9 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TNFRSF9 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TNFRSF9 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TNFRSF9 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TNFRSF9 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TNFRSF9 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TNFRSF9 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TNFRSF9 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TNFRSF9 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TNFRSF9 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFRSF9 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TNFRSF9 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TNFRSF9 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TNFRSF9 protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving TNFRSF9 protein from the PID Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TNFRSF9 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFRSF9 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TNFRSF9 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TNFRSF9 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TNFRSF9 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TNFRSF9 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TNFRSF9 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TNFRSF9 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TNFRSF9 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TNFRSF9 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TNFRSF9 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TNFRSF9 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TNFRSF9 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TNFRSF9 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TNFRSF9 protein from the WikiPathways Pathways 2024 dataset. | |